Luyan Pharma Co.,Ltd. (002788.SZ)
CNY 7.84
(0.26%)
CNY 7.84
(0.26%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.03 Billion CNY | 2.4% |
| 2022 | 769.93 Million CNY | 5.05% |
| 2021 | 732.94 Million CNY | 13.34% |
| 2020 | 646.7 Million CNY | 1.61% |
| 2019 | 636.45 Million CNY | 25.9% |
| 2018 | 505.51 Million CNY | 37.34% |
| 2017 | 368.07 Million CNY | 22.75% |
| 2016 | 299.86 Million CNY | 5.82% |
| 2015 | 283.36 Million CNY | -6.29% |
| 2014 | 302.39 Million CNY | 17.52% |
| 2013 | 257.32 Million CNY | 33.36% |
| 2012 | 192.94 Million CNY | 49.83% |
| 2011 | 128.77 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 203.49 Million CNY | -4.87% |
| 2024 Q2 | 157.16 Million CNY | -22.77% |
| 2024 Q3 | 209.79 Million CNY | 71.14% |
| 2023 Q2 | 197.59 Million CNY | 4.83% |
| 2023 Q4 | 213.91 Million CNY | 13.53% |
| 2023 FY | 788.42 Million CNY | 2.4% |
| 2023 Q3 | 188.41 Million CNY | -4.65% |
| 2023 Q1 | 188.49 Million CNY | -10.61% |
| 2022 Q3 | 191.64 Million CNY | 1.06% |
| 2022 FY | 769.93 Million CNY | 5.05% |
| 2022 Q4 | 210.85 Million CNY | 10.02% |
| 2022 Q2 | 189.64 Million CNY | 6.67% |
| 2022 Q1 | 177.78 Million CNY | -11.18% |
| 2021 FY | 732.94 Million CNY | 13.34% |
| 2021 Q3 | 185.7 Million CNY | 7.79% |
| 2021 Q4 | 200.16 Million CNY | 7.79% |
| 2021 Q2 | 172.28 Million CNY | -1.43% |
| 2021 Q1 | 174.78 Million CNY | -3.85% |
| 2020 Q3 | 163.7 Million CNY | 5.37% |
| 2020 Q2 | 155.36 Million CNY | 6.52% |
| 2020 FY | 646.7 Million CNY | 1.61% |
| 2020 Q1 | 145.86 Million CNY | -21.44% |
| 2020 Q4 | 181.77 Million CNY | 11.04% |
| 2019 Q3 | 163.57 Million CNY | 14.57% |
| 2019 FY | 636.45 Million CNY | 25.9% |
| 2019 Q2 | 142.77 Million CNY | -1.16% |
| 2019 Q1 | 144.44 Million CNY | -1.86% |
| 2019 Q4 | 185.66 Million CNY | 13.51% |
| 2018 Q2 | 116.24 Million CNY | 6.35% |
| 2018 Q4 | 147.18 Million CNY | 10.85% |
| 2018 FY | 505.51 Million CNY | 37.34% |
| 2018 Q3 | 132.77 Million CNY | 14.23% |
| 2018 Q1 | 109.3 Million CNY | -10.41% |
| 2017 Q1 | 76.75 Million CNY | -10.03% |
| 2017 FY | 368.07 Million CNY | 22.75% |
| 2017 Q3 | 88.75 Million CNY | 10.18% |
| 2017 Q4 | 122 Million CNY | 37.46% |
| 2017 Q2 | 80.55 Million CNY | 4.96% |
| 2016 Q1 | 69.57 Million CNY | -12.11% |
| 2016 Q2 | 72.47 Million CNY | 4.18% |
| 2016 Q4 | 85.3 Million CNY | 17.65% |
| 2016 FY | 299.86 Million CNY | 5.82% |
| 2016 Q3 | 72.5 Million CNY | 0.03% |
| 2015 Q4 | 79.15 Million CNY | 9.51% |
| 2015 Q1 | 68.63 Million CNY | 0.0% |
| 2015 Q3 | 72.28 Million CNY | 14.23% |
| 2015 FY | 283.36 Million CNY | -6.29% |
| 2015 Q2 | 63.28 Million CNY | -7.8% |
| 2014 FY | 302.39 Million CNY | 17.52% |
| 2013 FY | 257.32 Million CNY | 33.36% |
| 2012 FY | 192.94 Million CNY | 49.83% |
| 2011 FY | 128.77 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 1.36 Billion CNY | 23.856% |
| Yixintang Pharmaceutical Group Co., Ltd. | 4.78 Billion CNY | 78.308% |
| ZJAMP Group Co., Ltd. | 1.31 Billion CNY | 21.142% |
| Ji Yao Holding Group Co., Ltd. | 428.47 Million CNY | -142.24% |